miRNA
Mirxes, Universiti Kebangsaan Malaysia Partner on Colorectal Cancer Detection Test
The partners aim to develop a blood-based colorectal cancer test for the Malaysian market using Mirxes' proprietary microRNA technology.
City of Hope, TGen Win $4.5M Grant to Advance Pancreatic Cancer Liquid Biopsy Screening
A City of Hope-led consortium aims to validate a noninvasive screening test for pancreatic ductal adenocarcinoma in a large-scale, diverse cohort.
Aspira Women's Health Licenses Dana-Farber microRNA Signature; Firm Executes Reverse Stock Split
Aspira Women's Health has been evaluating Dana-Farber's microRNA technology for ovarian cancer detection since early 2021.
Hummingbird Diagnostics Developing miRNA-Based Immunotherapy Predictor on Heels of Positive Study
Premium
The company published a pilot study showing that it's five-miRNA signature could predict which lung cancer patients survived longer on immunotherapy treatment.
The company is working with three institutions to recruit about 1,200 case-control participants for its validation study, with plans to launch an LDT next year.
Nov 4, 2020
Mar 28, 2019